Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
159.62B
Market cap159.62B
Price-Earnings ratio
37.47
Price-Earnings ratio37.47
Dividend yield
6.08%
Dividend yield6.08%
Average volume
33.95M
Average volume33.95M
High today
$28.18
High today$28.18
Low today
$27.83
Low today$27.83
Open price
$28.00
Open price$28.00
Volume
31.17M
Volume31.17M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $28.02, with a market capitalization of 159.62B. The stock trades at a price-to-earnings (P/E) ratio of 37.47 and offers a dividend yield of 6.08%.

On 2026-08-27, Pfizer(PFE) stock traded between a low of $27.83 and a high of $28.18. Shares are currently priced at $28.02, which is +0.7% above the low and -0.6% below the high.

The Pfizer(PFE)'s current trading volume is 31.17M, compared to an average daily volume of 33.95M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

24/7 Wall St. 6h
Wall Street Is Sleeping on These 3 Ultra-High-Yield Dividend Stocks

Investing Wall Street Is Sleeping on These 3 Ultra-High-Yield Dividend Stocks Three famous dividend names trade well below their five-year highs while their CEO...

Wall Street Is Sleeping on These 3 Ultra-High-Yield Dividend Stocks
TipRanks 7h
Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. is reporting new data from its Korean post-marketing study of Vyndamax capsul...

Nasdaq 7h
PFE October 9th Options Begin Trading

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the October 9th expiration. At Stock Options Channel, our YieldBoost formula h...

PFE October 9th Options Begin Trading

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Nasdaq 11h
The Most Concerning Thing About Pfizer's Dividend Isn't What You Think

Key Points Pfizer's management is standing behind the company's dividend. Although earnings aren't covering the payment, the drug giant has ample cash to pay...

The Most Concerning Thing About Pfizer's Dividend Isn't What You Think
The Motley Fool 1d
My 2 Favorite Dividend Stocks to Buy in August

When a raging bull market eventually loses momentum, investors generally rotate into stable, income-generating stocks. When most stocks look expensive, dividend...

My 2 Favorite Dividend Stocks to Buy in August
TipRanks 3d
Pfizer Stock Is a Buy despite Declining Revenues

Pfizer (PFE) stock is a Buy despite declining revenue, in my view. Shares of the drugmaker have been modestly ahead of the S&P 500 (SPX) in 2026, helped by an u...

Simply Wall St 4d
Is Pfizer Stock Too Pricey for Its Earnings Outlook?

Pfizer stock has returned 16.1% over the past year after a weaker five year stretch, while the valuation checks and market multiples now point to a mixed pictur...

Is Pfizer Stock Too Pricey for Its Earnings Outlook?
TipRanks 5d
Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Summer Sale - Claim 70% Off TipRanks Unlock powerful...

Simply Wall St 6d
Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case?

In August 2026, Legal Bay LLC announced that Pfizer and plaintiffs' leadership had agreed to a Depo-Provera settlement program intended to resolve a large porti...

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case?
TipRanks 6d
Pfizer Advances PF-07248144 With Key Drug-Interaction Study Completion

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.